Skip to content
buyWeak

Sheila Gujrathi bought $301k of VTYX

director at Ventyx Biosciences, Inc.. 130,000 shares at an average of $2.31, traded Dec 23, 2024, filed Dec 26, 2024.

Conviction score
37
Value
$301k
130,000 shares
Holdings after
130,000
change unknown
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Director
    +15
  • Trade size
    $301k at market
    +14
  • Relative to holdings
    First purchase: no shares before this trade
    +8
  • Price context
    No price history yet
    0
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001415889-24-030180, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 23, 2024POpen-market purchase
Common Stockindirect: See Footnote
+130,000$2.31$301k130,000Dec 26, 2024

Related signals

Other insiders at Ventyx Biosciences, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
15Weak
VTYXsell
Ventyx Biosciences, Inc.
John Nuss
CHIEF SCIENTIFIC OFFICER
$2,019
1,887 shares
-0%
22Weak
VTYXsell
Ventyx Biosciences, Inc.
John Nuss
CHIEF SCIENTIFIC OFFICER
$50k
21,119 shares
-4%
5Weak
VTYXsell
Ventyx Biosciences, Inc.
John Nuss
CHIEF SCIENTIFIC OFFICER
$30k
13,161 shares
-3%
55Moderate
VTYXbuy
Ventyx Biosciences, Inc.
Raju Mohan
CEO AND PRESIDENT
$960k
500,000 shares
+30%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Sheila Gujrathi bought $301k of VTYX | InsiderTell